Canntab Therapeutics Ltd (CTABF)
0.0001
0.00 (0.00%)
USD |
OTCM |
Sep 27, 16:00
Canntab Therapeutics Revenue (Quarterly): -0.0164M for Feb. 28, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| February 28, 2023 | -0.0164M |
| November 30, 2022 | 0.013M |
| August 31, 2022 | 0.0298M |
| May 31, 2022 | 0.0311M |
| February 28, 2022 | 0.0381M |
| November 30, 2021 | 0.136M |
| August 31, 2021 | 0.0277M |
| May 31, 2021 | -0.6802M |
| February 28, 2021 | 0.3648M |
| November 30, 2020 | 0.287M |
| August 31, 2020 | |
| May 31, 2020 | |
| February 29, 2020 | |
| November 30, 2019 | |
| August 31, 2019 | 0.1008M |
| May 31, 2019 | 0.138M |
| February 28, 2019 | 0.0169M |
| November 30, 2018 | 0.0172M |
| August 31, 2018 | 0.0076M |
| May 31, 2018 | 0.0099M |
| March 31, 2018 | |
| February 28, 2018 | 0.0066M |
| Date | Value |
|---|---|
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | 0.6866M |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | -0.0031M |
| September 30, 2013 | |
| June 30, 2013 | 0.0067M |
| March 31, 2013 | |
| December 31, 2012 | 0.0017M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
-0.6802M
Minimum
May 2021
0.3648M
Maximum
Feb 2021
0.0231M
Average
0.0305M
Median
Revenue (Quarterly) Benchmarks
| Biosyntech Inc | -- |
| Cotinga Pharmaceuticals Inc | -- |
| Choom Holdings Inc | 3.344M |
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | 57.19M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.3058M |
| Total Expenses (Quarterly) | 0.3724M |
| EPS Diluted (Quarterly) | -0.0074 |